|
1 Company |
|
3 Products |
|
3 Products |
|
3 Mechanisms of Action |
|
0 Trials |
|
9 News |
|
- Trial completion: PSYCHOCOKE: Clinical and Genetic Factors Associated With Psychotic Symptoms Among Cocaine Abusers (clinicaltrials.gov) - Dec 8, 2016
P=N/A, N=417, Completed, Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting --> Completed
- Trial completion, Trial primary completion date: Lifestyle Intervention for Diabetes and Weight Management in Psychosis (clinicaltrials.gov) - Jun 18, 2016
P=N/A, N=120, Completed, Sponsor: Centre for Addiction and Mental Health
Recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> May 2015
- Trial primary completion date: PSYCHOCOKE: Clinical and Genetic Factors Associated With Psychotic Symptoms Among Cocaine Abusers (clinicaltrials.gov) - Dec 17, 2014
P=N/A, N=400, Recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> May 2015 Trial primary completion date: Oct 2014 --> Nov 2016
- Enrollment closed, Trial primary completion date: Lifestyle Intervention for Diabetes and Weight Management in Psychosis (clinicaltrials.gov) - Nov 7, 2014
P=N/A, N=120, Active, not recruiting, Sponsor: Centre for Addiction and Mental Health
Trial primary completion date: Oct 2014 --> Nov 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Dec 2015
- | methamphetamine / Generic mfg., haloperidol / Generic mfg., quetiapine / Generic mfg.
New P4 trial: Therapeutic Effect of Quetiapine on Methamphetamine-Induced Psychosis (clinicaltrials.gov) - Sep 9, 2013
P4, N=80, Completed, Sponsor: Chulalongkorn University
- Clinical: Lifestyle Intervention for Diabetes and Weight Management in Psychosis (clinicaltrials.gov) - Apr 9, 2013
P=N/A, N=120, Recruiting, Sponsor: Centre for Addiction and Mental Health
- Trial completion: Prevention of Weight Gain in Early Psychoses (clinicaltrials.gov) - Dec 3, 2012
P=N/A, N=70, Completed, Sponsor: Centre for Addiction and Mental Health
Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Dec 2015 Recruiting --> Completed
- Enrollment open: PSYCHOCOKE: Clinical and Genetic Factors Associated With Psychotic Symptoms Among Cocaine Abusers (clinicaltrials.gov) - Jun 13, 2012
P=N/A, N=400, Recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting --> Completed Not yet recruiting --> Recruiting
- quetiapine extended-release / Generic mfg.
Trial termination: Quetiapine XR in Schizophrenic Patients (clinicaltrials.gov) - Nov 9, 2011
P3, N=5, Terminated, Sponsor: Hannover Medical School
Not yet recruiting --> Recruiting Recruiting --> Terminated; Planned number of 30 subjects could not be recruited during recruitment phase.